Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- June 9, 2026
- Closes
- See announcement
- Program funding
- $450,000,000
- Expected awards
- 60
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.270
- Category
- Health
- Archives
- January 8, 2027
Program funding history
Awards made under Assistance Listing 93.270 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $25.9M
- FY2025 obligated
- $35.9M
- FY2026 (to date) obligated
- $22.3M
- Awards in window
- 69
Top recipients: National Alliance of State & Territorial Aids Directors, Colorado Department of Public Health & Environment, City of Philadelphia, State of Georgia Department of Public Health, Health and Human Resources, West Virginia Department of
Source: USAspending.gov · refreshed August 2026
Synopsis
This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings.
This multi-component NOFO includes two required components and two optional components:
Component 1: Outbreak Response and Surveillance (Required)
Component 2: Planning, Partnerships, and Promotion (Required)
Component 3: Testing, Treatment, and Prevention (Optional)
Component 4: Perinatal Hepatitis C Program (Optional)
This NOFO is alignment with CDC priorities.
Who can apply
- County governments
- Special district governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- City or township governments
- State governments
Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia. Local health agencies or their bona fide agents. If the city does not have a public health department, then the county covering the jurisdiction may apply (i.e., Los Angeles, CA covered by Los Angeles County and Phoenix, AZ covered by Maricopa County). All U.S. territories Bona fide agents must submit documentation that demonstrates their arrangement with the eligible applicant.
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.
New to federal funding? How to read an announcement · Who can apply · How grants work
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get an alert the day a matching federal grant posts: we read every new Grants.gov posting and score it, personalized to your organization. Free for 30 days, then $19/mo founding rate locked for life — the rate holds while your subscription stays active (Terms). Card required, cancel any time before day 31.
See pricing